Healthcare provider profile · identity verified

Michael John Sterns, M.D.

Family Practice · SUPERIOR, WI · NPI 1104230408

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	1554	1550
Shingrix	Varicella-Zoster Ge/As01b/Pf	1312	1025
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	789	788
Atorvastatin Calcium	Atorvastatin Calcium	768	223
Omeprazole	Omeprazole	409	103
Amlodipine Besylate	Amlodipine Besylate	389	114
Lisinopril	Lisinopril	388	111
Gabapentin	Gabapentin	296	71
Losartan Potassium	Losartan Potassium	295	83
Tamsulosin Hcl	Tamsulosin Hcl	279	76
Metoprolol Succinate	Metoprolol Succinate	255	68
Furosemide	Furosemide	229	61
Metformin Hcl Er	Metformin Hcl	208	56
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	191	38
Levothyroxine Sodium	Levothyroxine Sodium	181	41
Metformin Hcl	Metformin Hcl	178	45
Simvastatin	Simvastatin	159	47
Rosuvastatin Calcium	Rosuvastatin Calcium	148	37
Ozempic	Semaglutide	143	22
Metoprolol Tartrate	Metoprolol Tartrate	137	36
Hydrochlorothiazide	Hydrochlorothiazide	134	37
Allopurinol	Allopurinol	132	35
Carvedilol	Carvedilol	124	36
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	116	34
Warfarin Sodium	Warfarin Sodium	107	31
Albuterol Sulfate Hfa	Albuterol Sulfate	106	45
Potassium Chloride	Potassium Chloride	98	22
Fluoxetine Hcl	Fluoxetine Hcl	97	22
Sertraline Hcl	Sertraline Hcl	96	23
Donepezil Hcl	Donepezil Hcl	93	20
Xarelto	Rivaroxaban	92	20
Pioglitazone Hcl	Pioglitazone Hcl	88	25
Eliquis	Apixaban	85	21
Atenolol	Atenolol	82	22
Montelukast Sodium	Montelukast Sodium	81	18
Trazodone Hcl	Trazodone Hcl	81	27
Mirtazapine	Mirtazapine	75	23
Famotidine	Famotidine	72	28
Finasteride	Finasteride	72	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	71	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	66	15
Pantoprazole Sodium	Pantoprazole Sodium	65	24
Ropinirole Hcl	Ropinirole Hcl	65	14
Bupropion Xl	Bupropion Hcl	64	15
Duloxetine Hcl	Duloxetine Hcl	64	20
Fluticasone Propionate	Fluticasone Propionate	63	26
Ventolin Hfa	Albuterol Sulfate	58	22
Ezetimibe	Ezetimibe	57	17
Jardiance	Empagliflozin	57	14
Glimepiride	Glimepiride	56	15
Oxycodone Hcl	Oxycodone Hcl	54	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	15
Pravastatin Sodium	Pravastatin Sodium	52	13
Clopidogrel	Clopidogrel Bisulfate	51	16
Nitroglycerin	Nitroglycerin	51	37
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	50	suppressed
Buspirone Hcl	Buspirone Hcl	49	16
Clonazepam	Clonazepam	48	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	47	20
Prednisone	Prednisone	46	34
Spironolactone	Spironolactone	42	12
Venlafaxine Hcl Er	Venlafaxine Hcl	42	13
Oxybutynin Chloride Er	Oxybutynin Chloride	41	12
Glipizide Er	Glipizide	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	14
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	36	30
Farxiga	Dapagliflozin Propanediol	35	suppressed
Lorazepam	Lorazepam	35	14
Risperidone	Risperidone	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Enalapril Maleate	Enalapril Maleate	31	suppressed
Clonidine Hcl	Clonidine Hcl	29	11
Divalproex Sodium	Divalproex Sodium	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	11
Meloxicam	Meloxicam	29	suppressed
Terazosin Hcl	Terazosin Hcl	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Celecoxib	Celecoxib	26	14
Glipizide	Glipizide	26	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Trulicity	Dulaglutide	25	suppressed
Gemfibrozil	Gemfibrozil	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Diazepam	Diazepam	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Spiriva Handihaler	Tiotropium Bromide	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	suppressed
Brilinta	Ticagrelor	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Nystatin	Nystatin	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	11
Baclofen	Baclofen	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Torsemide	Torsemide	16	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Dilt-Xr	Diltiazem Hcl	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Topiramate	Topiramate	14	suppressed
Twinrix	Hepatitis A And B Vaccine/Pf	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Phenobarbital	Phenobarbital	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error